Amanta Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amanta Healthcare reported June 2025 quarter (Q1 FY26) revenue of ₹6,530.71 lakhs, down about 4% from ₹6,809.65 lakhs in Q1 FY25. The company swung to a profit after tax of ₹350.72 lakhs versus a loss of ₹36.19 lakhs in the same quarter last year, with EPS of ₹1.22. Profit before tax improved to ₹492.65 lakhs from a loss of ₹50.41 lakhs, helped by lower finance costs (prior year included a ₹309.73 lakh one-time charge from early redemption of non-convertible debentures). Auditor Price Waterhouse Chartered Accountants LLP issued an unmodified (clean) limited review opinion. Separately, the board approved redemption of 1 crore unlisted 14% non-convertible cumulative participating redeemable preference shares at ₹11.742 per share, totaling about ₹11.74 crore, payable from profits. This is the company's first quarterly filing since listing on NSE and BSE on September 9, 2025, following an IPO of 1 crore fresh equity shares at ₹126 each.
Modest top-line softness but a strong profitability turnaround from last year's loss position; clean auditor opinion is reassuring for new public shareholders. Preference share redemption clears high-cost capital from the books but uses accumulated profits that could otherwise have supported dividend payouts.